Biogen, Inc. (BIIB)
169.32
-8.98
(-5.04%)
USD |
NASDAQ |
Jan 14, 15:55
Biogen Market Cap: 24.84B for Jan. 14, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 961.55B |
| Stoke Therapeutics, Inc. | 1.778B |
| AbbVie, Inc. | 393.14B |
| Alnylam Pharmaceuticals, Inc. | 48.29B |
| Insmed, Inc. | 34.82B |
Market Cap Related Metrics
| PE Ratio | 15.44 |
| PS Ratio | 2.562 |
| Price to Book Value | 1.364 |
| Price to Free Cash Flow | 10.98 |
| Price | 169.32 |
| Earnings Yield | 6.48% |
| Operating PE Ratio | 10.18 |
| Normalized PE Ratio | 13.69 |